A new report shows that lowering drug costs in Medicare Part D by adopting international reference pricing would have a devastating effect on innovation.
Wrong Path to Lower Drug Costs
Comment
Show comments
Hide Comments
A new report shows that lowering drug costs in Medicare Part D by adopting international reference pricing would have a devastating effect on innovation.
